跳至主要内容
临床试验/NCT03455023
NCT03455023Unknown不适用

Impact of Individualized Pharmaceutical-care on Medication Adherence and Outcome of Cancer Pain in Opioid-tolerant Inpatients

Zhejiang Cancer Hospital1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2018年6月30日最近更新:
适应症

试验速览

阶段
不适用
入组人数
500
试验地点
1
主要终点
Change in medication adherence

研究概览

简要总结

The purpose of the study is to investigate the impact of pharmaceutical care on cancer pain treatment for opioid-tolerant inpatients

详细描述

This study is a prospective multicenter randomized controlled study to investigate the impact of pharmaceutical care on cancer pain treatment for opioid-tolerant inpatients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged 18 years or older;
  • Histologically confirmed solid tumor;
  • Diagnosed chronic cancer pain;
  • Opioid-tolerant patients;
  • Overall survival is expected to be over 3 months;
  • Karnofsky performance score≥50;
  • Willing and able to comply with the protocol

排除标准

  • Current pregnancy or breastfeeding;
  • Patients diagnosed with non-cancer pain;
  • Patients treated with patient-controlled analgesia;
  • Patients with pathological fracture, gastrointestinal obstruction, severe infection, non-opioid related intractable constipation;
  • Patients with mental disorder;
  • Creatinine clearance rate <15mL/min;
  • ALT or AST ≥ 10 fold of upper limit of normal value

结局指标

主要结局

Change in medication adherence

时间窗: Change from baseline at 1 month after discharge

The investigators will measure the change in medication adherence via Morisky Scale. Morisky Scale contains 4 questions, and the total score ranges from 0 to 4 with lower scores indicating higher adherence.

次要结局

  • Incidence of adverse events [safety and tolerability](Up to 1 month after discharge)
  • Change in quality of life(Change from baseline at 1 month after discharge)
  • Change in pain score(Change from baseline at 1 month after discharge)
  • Change in patients' knowledge of cancer pain and analgesics(Change from baseline at 1 month after discharge)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ping Huang

Chief of Pharmacy

Zhejiang Cancer Hospital

研究点 (1)

Loading locations...

相似试验

Individualized Pharmaceutical-care for Inpatients... | 临床试验